Valuation for Protalix BioTherapeutics Inc (id:185 PLX)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 13.00 |
|
|
| Forward P/E | 2.81 |
|
|
| Price to sales | 3.37 |
|
|
| Price to book | 3.78 |
|
|
| Enterprise to revenue | 2.23 |
|
|
| Enterprise to ebitda | -6.27 |
|
|